Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

US STOCKS-Wall Street rises as vaccine hopes firm after Moderna data

Published 16/11/2020, 16:18
© Reuters.
US500
-
DJI
-
US2000
-
UAL
-
IXIC
-
AAL
-
SPNY
-
RLVh
-
RLG
-
MRNA
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Moderna jumps after COVID-19 vaccine update; Pfizer falls
* Banks, airlines, cruise operators rally
* Stay-at-home winners Netflix, Amazon fall
* Indexes up: Dow 1.2%, S&P 0.8%, Nasdaq 0.6%

(Updates to market open)
By Medha Singh and Shivani Kumaresan
Nov 16 (Reuters) - Wall Street's main indexes rose on Monday
after Moderna became the second U.S. company in a week to report
positive results from its COVID-19 vaccine trial, raising hopes
of a quicker economic recovery from a pandemic-led recession.
Moderna Inc MRNA.O soared 8% as it said its experimental
vaccine was 94.5% effective in preventing COVID-19 based on
interim data from a late-stage trial. Nasdaq's .IXIC rise was limited as investors sold some of
this year's "stay-at-home" winners, although gains of about a
percent for Dow were less stellar than those following a similar
vaccine-related update from Pfizer Inc PFE.N a week earlier,
that briefly sent all the three main indexes to record highs.
"It's not the end of the virus issue, but it's the first
sign of the beginning of the end which is always taken as a
positive sign," said Randy Frederick, vice president of trading
and derivatives for Charles Schwab in Austin, Texas.
"We won't get a true impact from this until the vaccine is
manufactured and distributed widely, which probably won't happen
until Q1 next year."
Travel-related stocks including United Airlines Holdings Inc
UAL.O , American Airlines Group Inc AAL.O , Carnival Corp
CCL.N and Norwegian Cruise Line Holdings Ltd NCLH.N , which
have lost more than half their market capitalization this year
due to the pandemic, jumped between 3.7% and 9.0%.
Bets of a working COVID-19 vaccine fueled gains on Wall
Street last week, helping investors look past surging
coronavirus cases across the United States which topped the 11
million mark, just over a week after hitting 10 million.
The benchmark S&P 500 .SPX and the small-cap Russell 2000
.RUT ended Friday at record closing highs, while the
technology-heavy Nasdaq .IXIC fell slightly.
At 09:50 a.m. ET the Dow Jones Industrial Average .DJI
rose 360.47 points, or 1.22%, to 29,840.28, the S&P 500 .SPX
gained 29.36 points, or 0.82%, to 3,614.51 and the Nasdaq
Composite .IXIC gained 67.22 points, or 0.57%, to 11,896.50.
The S&P energy sector .SPNY added 3.0%, while banks
.SPXBK rose 2.2%, building on gains from last week.
Value shares .RLV , that comprise banks and energy stocks
and tend to outperform coming out of a recession, added about
1%, while growth shares .RLG , which are technology weighted,
were nearly flat.
Better-than-expected factory output data from China also
bolstered optimism about a rebound from a coronavirus-induced
slump, pushing global stocks closer to record highs on Monday.
MKTS/GLOB
Among other stocks, Simon Property Group Inc SPG.N jumped
6% after the biggest U.S. mall operator cut its purchase price
for an 80% stake of rival Taubman Centers Inc TCO.N , as the
virus outbreak upends the retail industry. Advancing issues outnumbered decliners by 4.6-to-1 on the
NYSE; on Nasdaq, a 3.3-to-1 ratio favored advancers.
The S&P 500 posted 24 new 52-week highs and no new low,
while the Nasdaq Composite recorded 155 new highs and five new
lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.